Emulex (NYSE: ELX ) reported earnings on May 2. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q3), Emulex beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue shrank. Non-GAAP earnings per share shrank. GAAP earnings per share contracted to a loss.
Margins contracted across the board.
Emulex chalked up revenue of $116.8 million. The 12 analysts polled by S&P Capital IQ looked for revenue of $112.6 million on the same basis. GAAP reported sales were 7.1% lower than the prior-year quarter's $125.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.20. The 13 earnings estimates compiled by S&P Capital IQ predicted $0.13 per share. Non-GAAP EPS of $0.20 for Q3 were 4.8% lower than the prior-year quarter's $0.21 per share. GAAP EPS were -$0.08 for Q3 versus $0.10 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 63.1%, 50 basis points worse than the prior-year quarter. Operating margin was -3.1%, much worse than the prior-year quarter. Net margin was -6.0%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $118.5 million. On the bottom line, the average EPS estimate is $0.13.
Next year's average estimate for revenue is $474.9 million. The average EPS estimate is $0.68.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Emulex is hold, with an average price target of $7.40.
Internet software and services are being consumed in radically different ways, on increasingly mobile devices. Does Emulex fit in anymore? Check out the company that Motley Fool analysts expect to lead the pack in "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Emulex to My Watchlist.